Revlon Reports Fourth Quarter and Full Year 2018 Results
Mar 18, 2019
Operating Income Growth Continued in the Fourth Quarter
Strong Growth in Key Sectors Including E-Commerce, Elizabeth Arden,
Quarter ended
- As Reported net sales were
$741.6 million in the fourth quarter of 2018, compared to$786.6 million during the prior-year period, a decrease of 5.7% versus the prior-year period. On a constant currency basis, net sales declined$28.9 million or 3.7% versus the prior-year period. The net sales decrease was driven by several one-time items including lower net sales in theRevlon segment due in part to the shift in timing of customer resets from the fourth quarter of 2018 into late first quarter of 2019 and lower net sales in the Fragrances segment driven by several expired brand licenses in 2018. The net sales decline was partially offset by strong double digit growth in the Elizabeth Arden segment, particularly within e-commerce, Travel Retail and strong results inChina . - As Reported operating income increased 65.1% to
$32.2 million in the fourth quarter of 2018, which included the impact of non-cash pre-tax items totaling$37.1 million , consisting of an$18.0 million goodwill impairment charge related to the Mass Portfolio reporting unit and$19.1 million of accelerated amortization related to Pure Ice brand intangible assets. The higher As Reported operating income was driven by lower selling, general and administrative expenses, mainly attributed to lower overhead costs and lower brand support in the Portfolio, Fragrances, and Elizabeth Arden segments due primarily to the re-phasing of marketing initiatives, as well as lower acquisition and integration costs in the fourth quarter of 2018. - As Reported net loss was
$70.3 million in the fourth quarter of 2018, representing an 8.6% improvement over the prior-year period. The lower net loss was driven by the higher operating income described above, partially offset by higher interest expense. As Reported net loss included the impact of non-cash after-tax items totaling$81.5 million , consisting of a$49.0 million non-cash increase in tax valuation allowances and the previously noted impairment and accelerated amortization items. - Adjusted EBITDA(a) of
$124.6 million in the fourth quarter of 2018 improved 12.8% compared to the prior-year period, primarily driven by the factors described above.
"We are very pleased with our continued momentum during the fourth quarter of 2018 as we successfully execute on our core strategies and business transformation. I am particularly encouraged by strong growth in some of the key areas that we have intensely focused on such as e-commerce, Elizabeth Arden skincare,
1 See "Notices to Investors - Unaudited Results" below in the footnotes to this release.
2 The results discussed include the following measures: U.S. GAAP (“As Reported”); and non-GAAP (“Adjusted”), which excludes certain Non-Operating Items and EBITDA Exclusions (as defined in Footnote (a)) from As Reported results. See footnote (a) for further discussion of the Company’s Adjusted measures. Reconciliations of As Reported results to Adjusted results are provided as an attachment to this release. In addition, where indicated, the Company analyzes and presents its results excluding the impact of foreign currency translation (“XFX”). Unless otherwise noted, the discussion is presented on an As Reported basis.
Fourth Quarter 2018 Results
Total Company Results
In calculating Adjusted results, adjustments were made for the Non-Operating Items, and the EBITDA Exclusions in the case of Adjusted EBITDA, in each case as described in footnote (a).
(USD millions, except per share data) |
Three Months Ended December 31, |
|||||||||||||||||||||
2018 | 2017 |
As |
Adjusted |
|||||||||||||||||||
As |
Adjusted |
As |
Adjusted |
% Change | % Change | |||||||||||||||||
Net Sales | $ | 741.6 | $ | 743.0 | $ | 786.6 | $ | 786.6 | (5.7 | )% | (5.5 | )% | ||||||||||
Gross Profit | 431.8 | 435.8 | 458.7 | 459.1 | (5.9 | )% | (5.1 | )% | ||||||||||||||
Gross Margin | 58.2 | % | 58.7 | % | 58.3 | % | 58.4 | % | -10bps | 30bps | ||||||||||||
Operating Income | $ | 32.2 | $ | 64.4 | $ | 19.5 | $ | 65.5 | 65.1 | % | (1.7 | )% | ||||||||||
Adjusted EBITDA | 124.6 | 110.5 | 12.8 | % | ||||||||||||||||||
Net Loss | (70.3 | ) | (45.7 | ) | (76.9 | ) | (45.2 | ) | 8.6 | % | (1.1 | )% | ||||||||||
Diluted Loss per Common Share | $ | (1.33 | ) | $ | (0.86 | ) | $ | (1.46 | ) | $ | (0.86 | ) | 8.9 | % | — | % |
(*) Refer to footnote (a) to this Earnings Release for a discussion and reconciliation of our non-GAAP measures, including Adjusted Net Sales, Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted Operating Income, Adjusted EBITDA, Adjusted Net Income (Loss) and Adjusted Diluted Loss per Common Share. |
Segment Results
Effective
Elizabeth Arden - The Elizabeth Arden segment is comprised of the Company's Elizabeth Arden branded products. The Elizabeth Arden segment markets, distributes and sells fragrances, skin care and color cosmetics primarily to prestige retailers, department and specialty stores, perfumeries, boutiques, e-commerce sites, the mass retail channel, travel retailers and distributors, as well as direct sales to consumers via its Elizabeth Arden branded retail stores and elizabetharden.com e-commerce website, in the U.S. and internationally, under brands such as Elizabeth Arden Ceramide, Prevage, Eight Hour, SUPERSTART, Visible Difference and Skin Illuminating in the Elizabeth Arden skin care brands; and
Portfolio - The Company’s Portfolio segment markets, distributes and sells a comprehensive line of premium, specialty and mass products primarily to the mass retail channel, hair and nail salons and professional salon distributors in the U.S. and internationally and large volume retailers, specialty and department stores under brands such as Almay and SinfulColors in color cosmetics; American Crew in men’s grooming products (which are also sold direct-to-consumer on its americancrew.com website); CND in nail polishes, gel nail color and nail enhancements; Mitchum in anti-perspirant deodorants; Cutex nail care products; and Pure Ice in nail polishes. The Portfolio segment also includes a multi-cultural hair care line consisting of Creme of Nature hair care products, which are sold in both professional salons and in large volume retailers and other retailers, primarily in the U.S.; and a body care line under the Natural Honey brand and a hair color line under the Llongueras brand (licensed from a third party) that are both sold in the mass retail channel, large volume retailers and other retailers, primarily in
Fragrances - The Fragrances segment includes the development, marketing and distribution of certain owned and licensed fragrances, as well as the distribution of prestige fragrance brands owned by third parties. These products are typically sold to retailers in the U.S. and internationally, including prestige retailers, specialty stores, e-commerce sites, the mass retail channel, travel retailers and other international retailers. The owned and licensed fragrances include brands such as Juicy Couture (which are also sold direct-to-consumer on its juicycouturebeauty.com website),
Effective
(USD millions) |
Three Months Ended December 31, |
||||||||||||||||||
Net Sales | |||||||||||||||||||
As Reported | As Reported | ||||||||||||||||||
2018 | 2017 | % Change | XFX % Change |
||||||||||||||||
Revlon | $ | 261.4 | $ | 301.5 | (13.3 | )% | (11.2 | )% | |||||||||||
Elizabeth Arden | 156.3 | 132.2 | 18.2 | % | 21.1 | % | |||||||||||||
Portfolio | 144.1 | 154.6 | (6.8 | )% | (4.0 | )% | |||||||||||||
Fragrances | 179.8 | 198.3 | (9.3 | )% | (8.5 | )% | |||||||||||||
Total | $ | 741.6 | $ | 786.6 | (5.7 | )% | (3.7 | )% | |||||||||||
Three Months Ended December 31, |
|||||||||||||||||||
Segment Profit | |||||||||||||||||||
As Reported | As Reported | ||||||||||||||||||
2018 | 2017 | % Change | XFX % Change |
||||||||||||||||
Revlon | $ | 54.0 | $ | 82.0 | (34.1 | )% | (32.1 | )% | |||||||||||
Elizabeth Arden | 22.1 | 4.6 | 380.4 | % | 402.2 | % | |||||||||||||
Portfolio | 13.7 | 0.4 | N.M. | N.M. | |||||||||||||||
Fragrances | 34.8 | 23.5 | 48.1 | % | 48.5 | % | |||||||||||||
Total | $ | 124.6 | $ | 110.5 | 12.8 | % | 15.9 | % |
Revlon Segment
Elizabeth Arden Segment
Elizabeth Arden segment net sales in the fourth quarter of 2018 were
Elizabeth Arden segment profit in the fourth quarter of 2018 was
Portfolio Segment
Portfolio segment net sales of
Portfolio segment profit in the fourth quarter of 2018 was
Fragrances Segment
Fragrances segment net sales of
As a result of the Fragrances segment's realization of cost reductions principally associated with insourcing production capabilities and lower brand support expenses, segment profit increased by 48.1% (or 48.5% XFX) in the fourth quarter of 2018 compared to the prior-year period, despite the lower net sales.
Geographic Net Sales
Overall, As Reported net sales decreased by 5.7%, as detailed below by segment for the Company's
(USD millions) |
Three Months Ended December 31, |
||||||||||||||||||
2018 As Reported |
2017 As Reported |
As Reported % Change |
As Reported |
||||||||||||||||
Net Sales: | |||||||||||||||||||
Revlon | |||||||||||||||||||
North America | $ | 134.1 | $ | 169.8 | (21.0 | )% | (20.8 | )% | |||||||||||
International | 127.3 | 131.7 | (3.3 | )% | 1.2 | % | |||||||||||||
Elizabeth Arden | |||||||||||||||||||
North America | $ | 39.4 | $ | 36.9 | 6.8 | % | 7.6 | % | |||||||||||
International | 116.9 | 95.3 | 22.7 | % | 26.3 | % | |||||||||||||
Portfolio | |||||||||||||||||||
North America | $ | 85.6 | $ | 89.5 | (4.4 | )% | (4.4 | )% | |||||||||||
International | 58.5 | 65.1 | (10.1 | )% | (3.8 | )% | |||||||||||||
Fragrances | |||||||||||||||||||
North America | $ | 129.0 | $ | 134.7 | (4.2 | )% | (4.1 | )% | |||||||||||
International | 50.8 | 63.6 | (20.1 | )% | (17.9 | )% | |||||||||||||
Total Net Sales 1 | $ | 741.6 | $ | 786.6 | (5.7 | )% | (3.8 | )% | |||||||||||
Total Net Sales Summary | |||||||||||||||||||
North America | $ | 388.1 | $ | 430.9 | (9.9 | )% | (9.8 | )% | |||||||||||
International | 353.5 | 355.7 | (0.6 | )% | 3.6 | % |
1 As Reported net sales in North America includes the impact of $1.4 million of costs incurred in the fourth quarter of 2018 related to the service level disruptions at the Company's Oxford, N.C. manufacturing facility. |
Revlon Segment
In
In International,
Elizabeth Arden Segment
In
In International, Elizabeth Arden segment net sales of
Portfolio Segment
In
In International, Portfolio segment net sales of
Fragrances Segment
In
In International, Fragrances segment net sales of
Cash Flow for the Full Year Period
Net cash used in operating activities in 2018 was
Liquidity Update
As of
As of
As previously reported in a Form 8-K filed with the
Full Year 2018 Results
- As Reported net sales were
$2,564.5 million in 2018 compared to$2,693.7 million in 2017, a 4.8% decrease due to declines in theRevlon , Fragrances and Portfolio segments, driven in part by approximately$64 million in net sales reductions associated with service level disruptions at the Company'sOxford, N.C. manufacturing facility related to the Company'sFebruary 2018 implementation of a new SAP enterprise resource planning system, partially offset by strong growth in the Elizabeth Arden segment. - As Reported operating loss was
$85.2 million in 2018 compared to an operating loss of$23.8 million in 2017, driven primarily by lower net sales, costs associated with remediating the SAP disruption at the Company'sOxford, N.C. manufacturing facility and a$20.1 million loss, primarily non-cash, related to reacquiring certain iconic Elizabeth Arden trademark rights, partially offset by lower integration and restructuring expenses, as well as lower selling, general and administrative expenses. - As Reported net loss was
$294.2 million in 2018 compared to a net loss of$183.2 million in 2017, with the higher net loss driven by the higher operating loss described above and higher interest expense, partially offset by a lower tax provision due to the impact of the U.S. Tax Act. - Adjusted EBITDA(a) was
$237.9 million in 2018 compared to$257.3 million in 2017, primarily driven by the factors described above including the impact of the SAP disruption at the Company'sOxford, N.C. manufacturing facility.
(USD millions, except per share data) |
Year Ended December 31, |
|||||||||||||||||||||
2018 | 2017 |
As |
Adjusted |
|||||||||||||||||||
As |
Adjusted |
As |
Adjusted |
% Change | % Change | |||||||||||||||||
Net Sales | $ | 2,564.5 | $ | 2,576.0 | $ | 2,693.7 | $ | 2,693.7 | (4.8 | )% | (4.4 | )% | ||||||||||
Gross Profit | 1,447.5 | 1,501.5 | 1,541.4 | 1,559.8 | (6.1 | )% | (3.7 | )% | ||||||||||||||
Gross Margin | 56.4 | % | 58.3 | % | 57.2 | % | 57.9 | % | -80bps | 40bps | ||||||||||||
Operating (Loss) Income | $ | (85.2 | ) | $ | 43.5 | $ | (23.8 | ) | $ | 94.7 | 258.0 | % | (54.1 | )% | ||||||||
Adjusted EBITDA | 237.9 | 257.3 | (7.5 | )% | ||||||||||||||||||
Net Loss | (294.2 | ) | (194.9 | ) | (183.2 | ) | (101.4 | ) | (60.6 | )% | (92.2 | )% | ||||||||||
Diluted Loss per Common Share | $ | (5.57 | ) | $ | (3.69 | ) | $ | (3.48 | ) | $ | (1.93 | ) | (60.1 | )% | (91.2 | )% |
(*) Refer to footnote (a) to this Earnings Release for a discussion and reconciliation of the Company's non-GAAP measures, including Adjusted Net Sales, Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted Operating Income (Loss), Adjusted EBITDA, Adjusted Net Income (Loss) and Adjusted Diluted Loss per Common Share. |
(USD millions) |
Year Ended December 31, |
||||||||||||||||
2018 As Reported |
2017 As Reported |
As Reported % Change |
As Reported |
||||||||||||||
Total Net Sales Summary | |||||||||||||||||
North America | $ | 1,354.2 | $ | 1,433.3 | (5.5 | )% | (5.5 | )% | |||||||||
International | 1,210.3 | 1,260.4 | (4.0 | )% | (4.1 | )% | |||||||||||
Total Net Sales | 2,564.5 | 2,693.7 | (4.8 | )% | (4.8 | )% |
2018 Results Conference Call
The Company will host a conference call with members of the investment community today,
Footnotes to Press Release
(a) Non-GAAP Financial Measures: EBITDA; Adjusted EBITDA; Adjusted net sales; Adjusted operating loss/income; Adjusted net income/loss; Adjusted gross profit; Adjusted gross profit margin; Adjusted diluted loss per common share and free cash flow (together, the “Non-GAAP Measures”) are non-GAAP financial measures. See the reconciliations of such Non-GAAP Measures to their most directly comparable GAAP measures in the accompanying financial tables, to the extent not otherwise directly reconciled in the Company’s financial results.
The Company defines EBITDA as income from continuing operations before interest, taxes, depreciation, amortization, gains/losses on foreign currency fluctuations, gains/losses on the early extinguishment of debt and miscellaneous expenses (the foregoing being the “EBITDA Exclusions”). The Company presents Adjusted EBITDA to exclude the EBITDA Exclusions, as well as the impact of non-cash stock compensation expense and certain other non-operating items that are not directly attributable to the Company's underlying operating performance (the “Non-Operating Items”). The following table identifies the Non-Operating Items excluded in the presentation of Adjusted EBITDA for all periods:
(USD millions) |
||||||||||
Income / (Loss) Adjustments to EBITDA |
Q4 2018 |
Q4 2017 |
||||||||
(Unaudited) | ||||||||||
Non-Operating Items: | ||||||||||
Non-cash stock compensation expense | $ | 2.4 | $ |
0.9 |
|
|||||
Restructuring and related charges | 8.3 | 22.2 | ||||||||
Acquisition and integration costs | 1.9 | 12.7 | ||||||||
Oxford SAP disruption-related charges | 4.0 | — | ||||||||
Impairment charge | 18.0 | 10.8 | ||||||||
Elizabeth Arden 2016 Business Transformation program | — | 0.3 | ||||||||
(USD millions) |
||||||||||
Income / (Loss) Adjustments to EBITDA |
YTD 2018 |
YTD 2017 |
||||||||
(Unaudited) | ||||||||||
Non-Operating Items: | ||||||||||
Non-cash stock compensation expense | $ | 17.2 | $ |
6.8 |
|
|||||
Restructuring and related charges | 23.1 | 34.5 | ||||||||
Acquisition and integration costs | 13.9 | 52.9 | ||||||||
Oxford SAP disruption-related charges | 53.6 | — | ||||||||
Loss on disposal of minority investment | 20.1 | — | ||||||||
Elizabeth Arden inventory purchase accounting adjustment, cost of sales | — | 17.2 | ||||||||
Impairment charge | 18.0 | 10.8 | ||||||||
Deferred compensation | — | 2.0 | ||||||||
Elizabeth Arden 2016 Business Transformation program | — | 1.1 | ||||||||
Adjusted net loss and adjusted diluted loss per common share exclude the after-tax impact of the Non-Operating Items from As Reported net loss.
The Company excludes the EBITDA Exclusions and Non-Operating Items, as applicable, in calculating the Non-GAAP Measures because the Company's management believes that some of these items may not occur in certain periods, the amounts recognized can vary significantly from period to period and/or these items do not facilitate an understanding of the Company's underlying operating performance.
Free cash flow is defined as net cash provided by operating activities, less capital expenditures for property, plant and equipment. Free cash flow excludes proceeds on sale of discontinued operations. Free cash flow does not represent the residual cash flow available for discretionary expenditures, as it excludes certain expenditures such as mandatory debt service requirements, which for the Company are significant.
The Company's management uses the Non-GAAP Measures as operating performance measures, and in the case of free cash flow, as a liquidity measure (in conjunction with GAAP financial measures), as an integral part of its reporting and planning processes and to, among other things: (i) monitor and evaluate the performance of the Company's business operations, financial performance and overall liquidity; (ii) facilitate management's internal comparisons of the Company's historical operating performance of its business operations; (iii) facilitate management's external comparisons of the results of its overall business to the historical operating performance of other companies that may have different capital structures and debt levels; (iv) review and assess the operating performance of the Company's management team and, together with other operational objectives, as a measure in evaluating employee compensation, including bonuses and other incentive compensation; (v) analyze and evaluate financial and strategic planning decisions regarding future operating investments; and (vi) plan for and prepare future annual operating budgets and determine appropriate levels of operating investments.
Management believes that the Non-GAAP Measures are useful to investors to provide them with disclosures of the Company's operating results on the same basis as that used by management. Management believes that the Non-GAAP Measures provide useful information to investors about the performance of the Company's overall business because such measures eliminate the effects of certain charges that are not directly attributable to the Company's underlying operating performance. Additionally, management believes that providing the Non-GAAP Measures enhances the comparability for investors in assessing the Company’s financial reporting. Management believes that free cash flow is useful for investors because it provides them with an important perspective on the cash available for debt service and other strategic measures, after making necessary capital investments in property and equipment to support the Company's ongoing business operations, and provides them with the same measures that management uses as the basis for making resource allocation decisions.
Accordingly, the Company believes that the presentation of the Non-GAAP Measures, when used in conjunction with GAAP financial measures, are useful financial analytical measures that are used by management, as described above, and therefore can assist investors in assessing the Company's financial condition, operating performance and underlying strength. The Non-GAAP Measures should not be considered in isolation or as a substitute for their respective most directly comparable As Reported financial measures prepared in accordance with GAAP, such as net income/loss, operating income/loss, diluted earnings/loss per share or net cash provided by (used in) operating activities. Other companies may define such non-GAAP measures differently. Also, while EBITDA and Adjusted EBITDA, as used in this release, are defined differently than Adjusted EBITDA for the Company's credit agreements and indentures, certain financial covenants in its borrowing arrangements are tied to similar financial measures. These non-GAAP financial measures should be read in conjunction with the Company's financial statements and related footnotes filed with the
(b) Segment profit is defined as income from continuing operations for each of the Company's
NOTICES TO INVESTORS
UNAUDITED RESULTS: On
FORWARD-LOOKING STATEMENTS: Statements made in this press release, which are not historical facts, are forward-looking and are provided pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date they are made and the Company undertakes no obligation to publicly update any forward-looking statement, whether to reflect actual results of operations; changes in financial condition; changes in general U.S. or international economic or industry conditions and/or conditions in the Company’s reportable segments; changes in estimates, expectations or assumptions; or other circumstances, conditions, developments and/or events arising after the issuance of this press release, except for the Company's ongoing obligations under the U.S. federal securities laws. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on preliminary or potentially inaccurate estimates and assumptions that could cause actual results to differ materially from those expected or implied by the estimated financial information. Such forward-looking statements include, among other things: (i) the Company belief in its continued momentum during the fourth quarter of 2018 as it successfully executes on its core strategies and business transformation and being particularly encouraged by strong growth in some of the key areas that the Company has intensely focused on such as e-commerce, Elizabeth Arden skincare,
REVLON, INC. AND SUBSIDIARIES | ||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS | ||||||||||||||||
(dollars in millions, except share and per share amounts) | ||||||||||||||||
Three Months Ended |
Year Ended |
|||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
(Unaudited) | (Unaudited) | |||||||||||||||
Net sales | $ | 741.6 | $ | 786.6 | $ | 2,564.5 | $ | 2,693.7 | ||||||||
Cost of sales | 309.8 | 327.9 | 1,117.0 | 1,152.3 | ||||||||||||
Gross profit | 431.8 | 458.7 | 1,447.5 | 1,541.4 | ||||||||||||
Selling, general and administrative expenses | 373.4 | 393.6 | 1,460.5 | 1,468.1 | ||||||||||||
Acquisition and integration costs | 1.9 | 12.7 | 13.9 | 52.9 | ||||||||||||
Restructuring charges and other, net | 6.3 | 22.1 | 20.2 | 33.4 | ||||||||||||
Impairment charge | 18.0 | 10.8 | 18.0 | 10.8 | ||||||||||||
Loss on disposal of minority investment | — | — | 20.1 | — | ||||||||||||
Operating income (loss) | 32.2 | 19.5 | (85.2 | ) | (23.8 | ) | ||||||||||
Other expenses: | ||||||||||||||||
Interest expense | 47.5 | 39.5 | 176.6 | 149.8 | ||||||||||||
Amortization of debt issuance costs | 3.9 | 2.3 | 13.0 | 9.1 | ||||||||||||
Foreign currency losses (gains), net | 5.1 | (1.7 | ) | 15.8 | (18.5 | ) | ||||||||||
Miscellaneous, net | 0.7 | (2.5 | ) | 1.3 | (0.7 | ) | ||||||||||
Other expenses | 57.2 | 37.6 | 206.7 | 139.7 | ||||||||||||
Loss from continuing operations before income taxes | (25.0 | ) | (18.1 | ) | (291.9 | ) | (163.5 | ) | ||||||||
Provision for income taxes | 45.3 | 59.6 | 2.2 | 21.8 | ||||||||||||
Loss from continuing operations, net of taxes | (70.3 | ) | (77.7 | ) | (294.1 | ) | (185.3 | ) | ||||||||
Income (loss) from discontinued operations, net of taxes | — | 0.8 | (0.1 | ) | 2.1 | |||||||||||
Net loss | $ | (70.3 | ) | $ | (76.9 | ) | $ | (294.2 | ) | $ | (183.2 | ) | ||||
Other comprehensive (loss) income: | ||||||||||||||||
Foreign currency translation adjustments, net of tax | 2.9 | 3.7 | (9.4 | ) | 9.0 | |||||||||||
Amortization of pension related costs, net of tax | 1.9 | 2.0 | 8.4 | 8.1 | ||||||||||||
Pension re-measurement, net of tax | (5.5 | ) | 1.8 | (5.5 | ) | 1.8 | ||||||||||
Pension curtailment, net of tax | — | (0.5 | ) | — | 2.1 | |||||||||||
Reclassification into earnings of accumulated losses from the de-designated 2013 Interest Rate Swap, net of tax | — | 0.5 | 0.7 | 2.3 | ||||||||||||
Other comprehensive (loss) income, net | (0.7 | ) | 7.5 | (5.8 | ) | 23.3 | ||||||||||
Total comprehensive loss | $ | (71.0 | ) | $ | (69.4 | ) | $ | (300.0 | ) | $ | (159.9 | ) | ||||
Basic (loss) earnings per common share: | ||||||||||||||||
Continuing operations | $ | (1.33 | ) | $ | (1.48 | ) | $ | (5.57 | ) | $ | (3.52 | ) | ||||
Discontinued operations | — | 0.02 | — | 0.04 | ||||||||||||
Net loss | $ | (1.33 | ) | $ | (1.46 | ) | $ | (5.57 | ) | $ | (3.48 | ) | ||||
Diluted (loss) earnings per common share: | ||||||||||||||||
Continuing operations | $ | (1.33 | ) | $ | (1.48 | ) | $ | (5.57 | ) | $ | (3.52 | ) | ||||
Discontinued operations | — | 0.02 | — | 0.04 | ||||||||||||
Net loss | $ | (1.33 | ) | $ | (1.46 | ) | $ | (5.57 | ) | $ | (3.48 | ) | ||||
Weighted average number of common shares outstanding: | ||||||||||||||||
Basic | 52,856,448 | 52,635,051 | 52,797,686 | 52,597,582 | ||||||||||||
Diluted | 52,856,448 | 52,635,051 | 52,797,686 | 52,597,582 | ||||||||||||
REVLON, INC. AND SUBSIDIARIES | ||||||||
CONSOLIDATED CONDENSED BALANCE SHEETS | ||||||||
(dollars in millions) | ||||||||
December 31, | December 31, | |||||||
2018 | 2017 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 87.3 | $ | 87.1 | ||||
Trade receivables, net | 431.3 | 444.8 | ||||||
Inventories | 523.2 | 497.9 | ||||||
Prepaid expenses and other current assets | 152.0 | 113.4 | ||||||
Total current assets | 1,193.8 | 1,143.2 | ||||||
Property, plant and equipment, net | 354.5 | 372.7 | ||||||
Deferred income taxes | 131.8 | 138.0 | ||||||
Goodwill | 673.9 | 692.5 | ||||||
Intangible assets, net | 532.0 | 592.1 | ||||||
Other assets | 130.8 | 118.4 | ||||||
Total assets | $ | 3,016.8 | $ | 3,056.9 | ||||
LIABILITIES AND STOCKHOLDERS' DEFICIENCY | ||||||||
Current liabilities: | ||||||||
Short-term borrowings | $ | 9.3 | $ | 12.4 | ||||
Current portion of long-term debt | 348.1 | 170.2 | ||||||
Accounts payable | 332.1 | 336.9 | ||||||
Accrued expenses and other current liabilities | 430.9 | 412.8 | ||||||
Total current liabilities | 1,120.4 | 932.3 | ||||||
Long-term debt | 2,727.7 | 2,653.7 | ||||||
Long-term pension and other post-retirement plan liabilities | 169.0 | 172.8 | ||||||
Other long-term liabilities | 56.5 | 68.5 | ||||||
Total stockholders' deficiency | (1,056.8 | ) | (770.4 | ) | ||||
Total liabilities and stockholders' deficiency | $ | 3,016.8 | $ | 3,056.9 | ||||
REVLON, INC. AND SUBSIDIARIES | ||||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||
(dollars in millions) | ||||||||||
Year Ended | ||||||||||
December 31, | ||||||||||
2018 | 2017 | |||||||||
(Unaudited) | ||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||||
Net loss | $ | (294.2 | ) | $ | (183.2 | ) | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||
Depreciation and amortization | 177.2 | 155.8 | ||||||||
Foreign currency losses (gains) from re-measurement | 15.8 | (22.5 | ) | |||||||
Amortization of debt discount | 1.4 | 1.2 | ||||||||
Stock-based compensation amortization | 17.2 | 6.8 | ||||||||
Impairment charge | 18.0 | 10.8 | ||||||||
Provision for deferred income taxes | 1.7 | 22.6 | ||||||||
Amortization of debt issuance costs | 13.0 | 9.1 | ||||||||
Non-cash loss on disposal of minority investment | 18.6 | — | ||||||||
Loss on sale of certain assets | 0.8 | 1.6 | ||||||||
Pension and other post-retirement cost | 2.6 | 1.5 | ||||||||
Change in assets and liabilities: | ||||||||||
Increase in trade receivables | (0.3 | ) | (9.9 | ) | ||||||
Increase in inventories | (36.4 | ) | (63.0 | ) | ||||||
Increase in prepaid expenses and other current assets | (42.8 | ) | (21.2 | ) | ||||||
Increase in accounts payable | 1.6 | 26.8 | ||||||||
Increase in accrued expenses and other current liabilities | 23.9 | 12.3 | ||||||||
Pension and other post-retirement plan contributions | (8.8 | ) | (8.5 | ) | ||||||
Purchases of permanent displays | (80.7 | ) | (65.5 | ) | ||||||
Other, net | 0.6 | (14.0 | ) | |||||||
Net cash used in operating activities | (170.8 | ) | (139.3 | ) | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||||
Capital expenditures | (57.2 | ) | (108.3 | ) | ||||||
Net cash used in investing activities | (57.2 | ) | (108.3 | ) | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||||
Net (decrease) increase in short-term borrowings and overdraft | (1.1 | ) | 3.3 | |||||||
Net borrowings under the 2016 Revolving Credit Facility | 178.0 | 157.0 | ||||||||
Net borrowings under the 2018 Foreign Asset-Based Term Loan | 88.9 | — | ||||||||
Repayments under the 2016 Term Loan Facility | (18.0 | ) | (18.0 | ) | ||||||
Payment of financing costs | (9.7 | ) | (1.2 | ) | ||||||
Tax withholdings related to net share settlements of restricted stock units and awards | (3.6 | ) | (2.5 | ) | ||||||
Other financing activities | (1.4 | ) | (1.7 | ) | ||||||
Net cash provided by financing activities | 233.1 | 136.9 | ||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (5.0 | ) | 11.3 | |||||||
Net increase (decrease) in cash, cash equivalents and restricted cash | 0.1 | (99.4 | ) | |||||||
Cash, cash equivalents and restricted cash at beginning of period | 87.4 | 186.8 | ||||||||
Cash, cash equivalents and restricted cash at end of period | $ | 87.5 | $ | 87.4 | ||||||
Supplemental schedule of cash flow information: | ||||||||||
Cash paid during the period for: | ||||||||||
Interest | $ | 163.7 | $ | 149.1 | ||||||
Income taxes, net of refunds | 16.0 | 0.4 | ||||||||
REVLON, INC. AND SUBSIDIARIES | ||||||||||
EBITDA AND ADJUSTED EBITDA RECONCILIATION | ||||||||||
(dollars in millions) | ||||||||||
Three Months Ended |
||||||||||
2018 | 2017 | |||||||||
(Unaudited) | ||||||||||
Reconciliation to net loss: | ||||||||||
Net loss | $ | (70.3 | ) | $ | (76.9 | ) | ||||
(Loss) income from discontinued operations, net of taxes | — | 0.8 | ||||||||
Loss from continuing operations, net of taxes | (70.3 | ) | (77.7 | ) | ||||||
Interest expense | 47.5 | 39.5 | ||||||||
Amortization of debt issuance costs | 3.9 | 2.3 | ||||||||
Foreign currency losses (gains), net | 5.1 | (1.7 | ) | |||||||
Provision for income taxes | 45.3 | 59.6 | ||||||||
Depreciation and amortization | 57.8 | 44.1 | ||||||||
Miscellaneous, net | 0.7 | (2.5 | ) | |||||||
EBITDA | $ | 90.0 | $ | 63.6 | ||||||
Non-operating items: | ||||||||||
Non-cash stock compensation expense | 2.4 | 0.9 | ||||||||
Restructuring and related charges | 8.3 | 22.2 | ||||||||
Acquisition and integration costs | 1.9 | 12.7 | ||||||||
Oxford SAP disruption-related charges | 4.0 | — | ||||||||
Impairment charge | 18.0 | 10.8 | ||||||||
Elizabeth Arden 2016 Business Transformation program | — | 0.3 | ||||||||
Adjusted EBITDA | $ | 124.6 | $ | 110.5 | ||||||
Year Ended |
||||||||||
2018 | 2017 | |||||||||
(Unaudited) | ||||||||||
Reconciliation to net loss: | ||||||||||
Net loss | $ | (294.2 | ) | $ | (183.2 | ) | ||||
(Loss) income from discontinued operations, net of taxes | (0.1 | ) | 2.1 | |||||||
Loss from continuing operations, net of taxes | (294.1 | ) | (185.3 | ) | ||||||
Interest expense | 176.6 | 149.8 | ||||||||
Amortization of debt issuance costs | 13.0 | 9.1 | ||||||||
Foreign currency losses (gains), net | 15.8 | (18.5 | ) | |||||||
Provision for income taxes | 2.2 | 21.8 | ||||||||
Depreciation and amortization | 177.2 | 155.8 | ||||||||
Miscellaneous, net | 1.3 | (0.7 | ) | |||||||
EBITDA | $ | 92.0 | $ | 132.0 | ||||||
Non-operating items: | ||||||||||
Non-cash stock compensation expense | 17.2 | 6.8 | ||||||||
Restructuring and related charges | 23.1 | 34.5 | ||||||||
Acquisition and integration costs | 13.9 | 52.9 | ||||||||
Oxford SAP disruption-related charges | 53.6 | — | ||||||||
Impairment charge | 18.0 | 10.8 | ||||||||
Loss on disposal of minority investment | 20.1 | — | ||||||||
Elizabeth Arden inventory purchase accounting adjustment, cost of sales | — | 17.2 | ||||||||
Deferred compensation | — | 2.0 | ||||||||
Elizabeth Arden 2016 Business Transformation program | — | 1.1 | ||||||||
Adjusted EBITDA | $ | 237.9 | $ | 257.3 | ||||||
REVLON, INC. AND SUBSIDIARIES | ||||||||||
SEGMENT PROFIT, ADJUSTED EBITDA AND ADJUSTED OPERATING LOSS RECONCILIATION | ||||||||||
(dollars in millions) | ||||||||||
Three Months Ended |
||||||||||
2018 | 2017 | |||||||||
(Unaudited) | ||||||||||
Segment Net Sales: | ||||||||||
Revlon | $ | 261.4 | $ | 301.5 | ||||||
Elizabeth Arden | 156.3 | 132.2 | ||||||||
Portfolio | 144.1 | 154.6 | ||||||||
Fragrances | 179.8 | 198.3 | ||||||||
Total Segment Net Sales | $ | 741.6 | $ | 786.6 | ||||||
Segment Profit: | ||||||||||
Revlon | $ | 54.0 | $ | 82.0 | ||||||
Elizabeth Arden | 22.1 | 4.6 | ||||||||
Portfolio | 13.7 | 0.4 | ||||||||
Fragrances | 34.8 | 23.5 | ||||||||
Total Segment Profit/Adjusted EBITDA | $ | 124.6 | $ | 110.5 | ||||||
Reconciliation to loss from continuing operations before income taxes: | ||||||||||
Loss from continuing operations before income taxes | $ | (25.0 | ) | $ | (18.1 | ) | ||||
Interest expense | 47.5 | 39.5 | ||||||||
Amortization of debt issuance costs | 3.9 | 2.3 | ||||||||
Foreign currency losses (gains), net | 5.1 | (1.7 | ) | |||||||
Miscellaneous, net | 0.7 | (2.5 | ) | |||||||
Operating income | 32.2 | 19.5 | ||||||||
Non-operating items: | ||||||||||
Restructuring and related charges | 8.3 | 22.2 | ||||||||
Acquisition and integration costs | 1.9 | 12.7 | ||||||||
Oxford SAP disruption-related charges | 4.0 | — | ||||||||
Impairment charge | 18.0 | 10.8 | ||||||||
Elizabeth Arden 2016 Business Transformation program | — | 0.3 | ||||||||
Adjusted Operating income | 64.4 | 65.5 | ||||||||
Non-cash stock compensation expense | 2.4 | 0.9 | ||||||||
Depreciation and amortization | 57.8 | 44.1 | ||||||||
Adjusted EBITDA | $ | 124.6 | $ | 110.5 | ||||||
REVLON, INC. AND SUBSIDIARIES | ||||||||||
SEGMENT PROFIT, ADJUSTED EBITDA AND ADJUSTED OPERATING LOSS RECONCILIATION | ||||||||||
(dollars in millions) | ||||||||||
Year Ended |
||||||||||
2018 | 2017 | |||||||||
(Unaudited) | ||||||||||
Segment Net Sales: | ||||||||||
Revlon | $ | 998.3 | $ | 1,089.3 | ||||||
Elizabeth Arden | 490.2 | 433.8 | ||||||||
Portfolio | 564.6 | 592.5 | ||||||||
Fragrances | 511.4 | 578.1 | ||||||||
Total Segment Net Sales | $ | 2,564.5 | $ | 2,693.7 | ||||||
Segment Profit: | ||||||||||
Revlon | $ | 129.6 | $ | 180.1 | ||||||
Elizabeth Arden | 24.4 | 6.9 | ||||||||
Portfolio | 7.9 | 8.1 | ||||||||
Fragrances | 76.0 | 62.2 | ||||||||
Total Segment Profit/Adjusted EBITDA | $ | 237.9 | $ | 257.3 | ||||||
Reconciliation to loss from continuing operations before income taxes: | ||||||||||
Loss from continuing operations before income taxes | $ | (291.9 | ) | $ | (163.5 | ) | ||||
Interest expense | 176.6 | 149.8 | ||||||||
Amortization of debt issuance costs | 13.0 | 9.1 | ||||||||
Foreign currency losses (gains), net | 15.8 | (18.5 | ) | |||||||
Miscellaneous, net | 1.3 | (0.7 | ) | |||||||
Operating loss | (85.2 | ) | (23.8 | ) | ||||||
Non-operating items: | ||||||||||
Restructuring and related charges | 23.1 | 34.5 | ||||||||
Acquisition and integration costs | 13.9 | 52.9 | ||||||||
Oxford SAP disruption-related charges | 53.6 | — | ||||||||
Loss on disposal of minority investment | 20.1 | — | ||||||||
Elizabeth Arden inventory purchase accounting adjustment, cost of sales | — | 17.2 | ||||||||
Impairment charge | 18.0 | 10.8 | ||||||||
Deferred compensation | — | 2.0 | ||||||||
Elizabeth Arden 2016 Business Transformation program | — | 1.1 | ||||||||
Adjusted Operating income | 43.5 | 94.7 | ||||||||
Non-cash stock compensation expense | 17.2 | 6.8 | ||||||||
Depreciation and amortization | 177.2 | 155.8 | ||||||||
Adjusted EBITDA | $ | 237.9 | $ | 257.3 | ||||||
REVLON, INC. AND SUBSIDIARIES | ||||||||||||
ADJUSTED NET SALES RECONCILIATION | ||||||||||||
(dollars in millions) | ||||||||||||
Three Months Ended | ||||||||||||
December 31, | ||||||||||||
2018 | 2017 | |||||||||||
(Unaudited) | ||||||||||||
Net Sales | $ | 741.6 | $ |
786.6 |
|
|||||||
Non-operating items: | ||||||||||||
Oxford SAP disruption-related charges | 1.4 | — | ||||||||||
Adjusted Net Sales | $ | 743.0 | $ | 786.6 | ||||||||
Year Ended | ||||||||||||
December 31, | ||||||||||||
2018 | 2017 | |||||||||||
(Unaudited) | ||||||||||||
Net Sales | $ | 2,564.5 | $ | 2,693.7 | ||||||||
Non-operating items: | ||||||||||||
Oxford SAP disruption-related charges | 11.5 | — | ||||||||||
Adjusted Net Sales | $ | 2,576.0 | $ | 2,693.7 | ||||||||
REVLON, INC. AND SUBSIDIARIES | ||||||||||||
ADJUSTED GROSS PROFIT RECONCILIATION | ||||||||||||
(dollars in millions) | ||||||||||||
Three Months Ended |
||||||||||||
2018 | 2017 | |||||||||||
(Unaudited) | ||||||||||||
Gross Profit | $ | 431.8 | $ |
458.7 |
|
|||||||
Non-operating items: | ||||||||||||
Restructuring and related charges | — | 0.4 | ||||||||||
Oxford SAP disruption-related charges | 4.0 | — | ||||||||||
Adjusted Gross Profit | $ | 435.8 | $ | 459.1 | ||||||||
Year Ended |
||||||||||||
2018 | 2017 | |||||||||||
(Unaudited) | ||||||||||||
Gross Profit | $ | 1,447.5 | $ | 1,541.4 | ||||||||
Non-operating items: | ||||||||||||
Restructuring and related charges | 0.4 | 0.9 | ||||||||||
Oxford SAP disruption-related charges | 53.6 | — | ||||||||||
Elizabeth Arden inventory purchase accounting adjustment, cost of sales | — | 17.2 | ||||||||||
Elizabeth Arden 2016 Business Transformation program | — | 0.3 | ||||||||||
Adjusted Gross Profit | $ | 1,501.5 | $ | 1,559.8 | ||||||||
REVLON, INC. AND SUBSIDIARIES | ||||||||||||
ADJUSTED NET LOSS AND ADJUSTED DILUTED LOSS PER SHARE RECONCILIATION | ||||||||||||
(dollars in millions, except share and per share amounts) | ||||||||||||
Three Months Ended |
||||||||||||
2018 | 2017 | |||||||||||
(Unaudited) | ||||||||||||
Reconciliation to net loss and diluted loss per share: | ||||||||||||
Net loss | $ | (70.3 | ) | $ | (76.9 | ) | ||||||
Non-operating items (after-tax): | ||||||||||||
Restructuring and related charges | 6.6 | 15.5 | ||||||||||
Acquisition and integration costs | 1.3 | 8.6 | ||||||||||
Oxford SAP disruption-related charges | 3.1 | — | ||||||||||
Impairment charge | 13.6 | 7.4 | ||||||||||
Elizabeth Arden 2016 Business Transformation program | — | 0.2 | ||||||||||
Adjusted net income (loss) | $ | (45.7 | ) | $ | (45.2 | ) | ||||||
Net income (loss): | ||||||||||||
Diluted loss per common share | (1.33 | ) | (1.46 | ) | ||||||||
Adjustment to diluted loss per common share | 0.47 | 0.60 | ||||||||||
Adjusted diluted earnings (loss) per common share | $ | (0.86 | ) | $ | (0.86 | ) | ||||||
U.S. GAAP weighted average number of common shares outstanding: | ||||||||||||
Diluted | 52,856,448 | 52,635,051 | ||||||||||
Year Ended |
||||||||||||
2018 | 2017 | |||||||||||
(Unaudited) | ||||||||||||
Reconciliation to net loss and diluted loss per share: | ||||||||||||
Net loss | $ | (294.2 | ) | $ | (183.2 | ) | ||||||
Non-operating items (after-tax): | ||||||||||||
Restructuring and related charges | 18.8 | 24.8 | ||||||||||
Acquisition and integration costs | 10.7 | 34.2 | ||||||||||
Oxford SAP disruption-related charges | 40.7 | — | ||||||||||
Loss on disposal of minority investment | 15.5 | — | ||||||||||
Elizabeth Arden inventory purchase accounting adjustment, cost of sales | — | 12.7 | ||||||||||
Impairment charge | 13.6 | 7.4 | ||||||||||
Deferred compensation | — | 2.0 | ||||||||||
Elizabeth Arden 2016 Business Transformation program | — | 0.7 | ||||||||||
Adjusted net loss | $ | (194.9 | ) | $ | (101.4 | ) | ||||||
Net (loss) income: | ||||||||||||
Diluted loss per common share | (5.57 | ) | (3.48 | ) | ||||||||
Adjustment to diluted loss per common share | 1.88 | 1.55 | ||||||||||
Adjusted diluted (loss) earnings per common share | $ | (3.69 | ) | $ | (1.93 | ) | ||||||
U.S. GAAP weighted average number of common shares outstanding: | ||||||||||||
Diluted | 52,797,686 | 52,597,582 | ||||||||||
REVLON, INC. AND SUBSIDIARIES | ||||||||||||
FREE CASH FLOW RECONCILIATION | ||||||||||||
(dollars in millions) | ||||||||||||
Year Ended |
||||||||||||
2018 | 2017 | |||||||||||
(Unaudited) | ||||||||||||
Reconciliation to net cash used in operating activities: | ||||||||||||
Net cash used in operating activities | $ | (170.8 | ) | $ | (139.3 | ) | ||||||
Less capital expenditures | (57.2 | ) | (108.3 | ) | ||||||||
Free cash flow | $ | (228.0 | ) | $ | (247.6 | ) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20190318005754/en/
Source:
Investor Relations:
212-527-5230 or Eric.warren@revlon.com